Insider Transactions in Q1 2025 at Neogenomics Inc (NEO)
Insider Transaction List (Q1 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 23
2025
|
Warren Stone Chief Commerical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,472
-2.65%
|
-
|
Feb 23
2025
|
Warren Stone Chief Commerical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,443
+8.3%
|
-
|
Feb 23
2025
|
Melody Harris Chf Ops Off, Pres, Informatics |
SELL
Payment of exercise price or tax liability
|
Direct |
2,056
-1.84%
|
-
|
Feb 23
2025
|
Melody Harris Chf Ops Off, Pres, Informatics |
BUY
Exercise of conversion of derivative security
|
Direct |
8,443
+7.02%
|
-
|
Feb 23
2025
|
Alicia C Olivo EVP, GC & Business Development |
SELL
Payment of exercise price or tax liability
|
Direct |
2,504
-5.23%
|
-
|
Feb 23
2025
|
Alicia C Olivo EVP, GC & Business Development |
BUY
Exercise of conversion of derivative security
|
Direct |
8,443
+15.0%
|
-
|
Feb 23
2025
|
Christopher M Smith Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,067
-2.15%
|
-
|
Feb 23
2025
|
Christopher M Smith Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
57,413
+8.05%
|
-
|
Feb 23
2025
|
Jeffrey Scott Sherman Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,207
-2.98%
|
-
|
Feb 23
2025
|
Jeffrey Scott Sherman Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,535
+9.91%
|
-
|
Jan 01
2025
|
Melody Harris Chf Ops Off, Pres, Informatics |
SELL
Payment of exercise price or tax liability
|
Direct |
7,070
-6.43%
|
-
|